piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: a step-toward ncRNA-precision.

Shaker, Fatma H; Sanad, Eman F; Elghazaly, Hesham; Hsia, Shih-Min; Hamdy, Nadia M

Shaker, Fatma H; Sanad, Eman F; Elghazaly, Hesham; Hsia, Shih-Min; Hamdy, Nadia M.

Afiliação

Shaker FH; Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Abassia, 11566, Egypt.
Sanad EF; Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Abassia, 11566, Egypt.
Elghazaly H; Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Cairo, Abassia, 11566, Egypt.
Hsia SM; School of Food and Safety, Nutrition Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei, 110301, Taiwan.
Hamdy NM; Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei, 110301, Taiwan.

Naunyn Schmiedebergs Arch Pharmacol ; 2024 Aug 05.

Article em En | MEDLINE | ID: mdl-39102033

Palavras-chave

Cancer hallmarks; In silico; Precision; ncRNA; piR-823; piRNA

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Egito

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google